中国临床医学2025，Vol.32Issue(1)：3-8,6.DOI:10.12025/j.issn.1008-6358.2025.20250142
钇-90选择性内放射治疗肝癌的过去、现在与未来
Yttrium-90 selective internal radiation therapy on liver cancer:the past,the present,and the future
摘要
Abstract
Yttrium-90 selective internal radiation therapy(90Y-SIRT)is a treatment technique that delivers radioactive microspheres precisely to the arterial vascular bed of neoplasms,utilizing beta radiation to administer a high local dose of radiation to the neoplasm tissues.This technology has demonstrated significant efficacy in patients with unresectable pirmary liver cancers and liver metastases.This article systematically reviews the development history and clinical application status of 90Y-SIRT in the treatment of liver cancer,and looks forward to future development directions.关键词
钇-90/选择性内放射治疗/肝癌Key words
Yttrium-90/selective internal radiation therapy/liver cancer分类
临床医学引用本文复制引用
马婧嶔,张林泓,杨敏捷,蔡加彬,方颖,刘嵘,瞿旭东,刘凌晓,颜志平..钇-90选择性内放射治疗肝癌的过去、现在与未来[J].中国临床医学,2025,32(1):3-8,6.基金项目
国家自然科学基金(82302323),上海市科学技术委员会基金(22ZR1460800).Supported by National Natural Science Foundation of China(82302323)and Foundation of Shanghai Municipal Science and Technology Commission(22ZR1460800). （82302323）
